Physician profile
Bruce E Thomas
NPI 1336173863
$772.58
in general payments reported to CMS, 2019-2025
18 companies · $139 in 2025
The $139 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $74.37 · 2020: $26.22 · 2021: $83.55 · 2022: $65.03 · 2023: $76.54 · 2024: $308 · 2025: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $523.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $523.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $104.73 | 2023-2025 | |
| Novo Nordisk INC | $94.73 | 2021-2025 | Rybelsus, Ozempic |
| Lilly USA, LLC | $83.76 | 2020-2025 | Mounjaro, Zepbound |
| Abbvie INC. | $74.12 | 2023-2025 | Vraylar |
| Glaxosmithkline, LLC. | $56.78 | 2022-2024 | Bexsero, Arexvy, Shingrix |
| Seqirus USA INC | $53.32 | 2025 | Flucelvax, Fluad |
| Boehringer Ingelheim Pharmaceuticals, INC. | $52.73 | 2022-2024 | Ofev, Jardiance |
| Exact Sciences Corporation | $51.26 | 2023-2024 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals Lp | $42.73 | 2019-2024 | Breztri |
| Astellas Pharma US INC | $24.45 | 2024 | Veozah |
| E.R. Squibb & Sons, L.L.C. | $22.09 | 2019 | |
| Inspire Medical Systems, INC. | $21.43 | 2024 | Inspire |
| Cequr Corporation | $19.05 | 2024 | Cequr Simplicity |
| Ironshore Pharmaceuticals INC. | $18.94 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $15.45 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $13.08 | 2023 | |
| Novartis Pharmaceuticals Corporation | $12.61 | 2019 | |
| Merck Sharp & Dohme LLC | $11.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.